Invention Grant
- Patent Title: Mutant-selective EGFR inhibitors and uses thereof
- Patent Title (中): 突变选择性EGFR抑制剂及其用途
-
Application No.: US14448578Application Date: 2014-07-31
-
Publication No.: US09409887B2Publication Date: 2016-08-09
- Inventor: Kwangho Lee , Deqiang Niu , Matthew F. Baevsky
- Applicant: Celgene Avilomics Research, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Celgene Avilomics Research, Inc.
- Current Assignee: Celgene Avilomics Research, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Choate, Hall & Stewart LLP
- Agent Charles E. Lyon; Kristen C. Buteau
- Main IPC: C07D403/12
- IPC: C07D403/12 ; C07D239/48 ; C12N9/12 ; A61K31/155 ; A61K45/06 ; C07D239/42 ; C07D239/47
Abstract:
The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
Public/Granted literature
- US20150025055A1 MUTANT-SELECTIVE EGFR INHIBITORS AND USES THEREOF Public/Granted day:2015-01-22
Information query
